Literature DB >> 31366298

Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Bharath Chelluboina1, Raghu Vemuganti1,2.   

Abstract

Chronic kidney disease has a graded and independent inverse impact on cerebrovascular health. Both thrombotic and hemorrhagic complications are highly prevalent in chronic kidney disease patients. Growing evidence suggests that in chronic kidney disease patients, ischemic strokes are more common than hemorrhagic strokes. Chronic kidney disease is asymptomatic until an advanced stage, but mild to moderate chronic kidney disease incites various pathogenic mechanisms such as inflammation, oxidative stress, neurohormonal imbalance, formation of uremic toxins and vascular calcification which damage the endothelium and blood vessels. Cognitive dysfunction, dementia, transient infarcts, and white matter lesions are widespread in mild to moderate chronic kidney disease patients. Uremic toxins produced after chronic kidney disease can pass through the blood-brain barrier and mediate cognitive dysfunction and neurodegeneration. Furthermore, chronic kidney disease precipitates vascular risk factors that can lead to atherosclerosis, hypertension, atrial fibrillation, and diabetes. Chronic kidney disease also exacerbates stroke pathogenesis, worsens recovery outcomes, and limits the eligibility of stroke patients to receive available stroke therapeutics. This review highlights the mechanisms involved in the advancement of chronic kidney disease and its possible association with stroke.

Entities:  

Keywords:  Thrombolysis; brain damage; inflammation; peripheral organ disease; vascular fibrosis

Mesh:

Year:  2019        PMID: 31366298      PMCID: PMC6775591          DOI: 10.1177/0271678X19866733

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  180 in total

1.  The association between age and nephrosclerosis on renal biopsy among healthy adults.

Authors:  Andrew D Rule; Hatem Amer; Lynn D Cornell; Sandra J Taler; Fernando G Cosio; Walter K Kremers; Stephen C Textor; Mark D Stegall
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

Review 2.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

3.  SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Authors:  Xiaoxin X Wang; Jonathan Levi; Yuhuan Luo; Komuraiah Myakala; Michal Herman-Edelstein; Liru Qiu; Dong Wang; Yingqiong Peng; Almut Grenz; Scott Lucia; Evgenia Dobrinskikh; Vivette D D'Agati; Hermann Koepsell; Jeffrey B Kopp; Avi Z Rosenberg; Moshe Levi
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

Review 4.  Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure.

Authors:  Tsering Dhondup; Qi Qian
Journal:  Blood Purif       Date:  2017-01-24       Impact factor: 2.614

5.  Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts.

Authors:  Bakhtawar K Mahmoodi; Hiroshi Yatsuya; Kunihiro Matsushita; Yinying Sang; Rebecca F Gottesman; Brad C Astor; Mark Woodward; W T Longstreth; Bruce M Psaty; Michael G Shlipak; Aaron R Folsom; Ron T Gansevoort; Josef Coresh
Journal:  Stroke       Date:  2014-05-29       Impact factor: 7.914

6.  Contribution of uraemic toxins to the vascular fibrosis associated with chronic kidney disease.

Authors:  Marco Hatem-Vaquero; Sergio de Frutos; Alicia Luengo; Alba González Abajo; Mercedes Griera; Manuel Rodríguez-Puyol; Diego Rodríguez-Puyol; Laura Calleros
Journal:  Nefrologia (Engl Ed)       Date:  2018-10-15

Review 7.  Interactions between kidney disease and diabetes: dangerous liaisons.

Authors:  Roberto Pecoits-Filho; Hugo Abensur; Carolina C R Betônico; Alisson Diego Machado; Erika B Parente; Márcia Queiroz; João Eduardo Nunes Salles; Silvia Titan; Sergio Vencio
Journal:  Diabetol Metab Syndr       Date:  2016-07-28       Impact factor: 3.320

8.  The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.

Authors:  Filipa Caeiro Alves; Jia Sun; Abdul Rashid Qureshi; Lu Dai; Sunna Snaedal; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Peter Stenvinkel
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

Review 9.  Circulating endothelial cells and chronic kidney disease.

Authors:  Kunying Zhang; Fang Yin; Lin Lin
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

10.  Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Elena Rusu; Diana Zilisteanu; Radu Albulescu; Gabriela Anton; Cristiana Tanase
Journal:  Dis Markers       Date:  2016-09-07       Impact factor: 3.434

View more
  16 in total

1.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 2.  Brain-kidney interaction: Renal dysfunction following ischemic stroke.

Authors:  Qiang Zhao; Tao Yan; Michael Chopp; Poornima Venkat; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-25       Impact factor: 6.200

3.  Cystatin C, cognition, and brain MRI findings in 90+-year-olds.

Authors:  Wei Ling Lau; Mark Fisher; Dana Greenia; David Floriolli; Evan Fletcher; Baljeet Singh; Seyed Ahmad Sajjadi; Maria M Corrada; Christina Whittle; Claudia Kawas; Annlia Paganini-Hill
Journal:  Neurobiol Aging       Date:  2020-04-29       Impact factor: 4.673

4.  A Control Region Near the Fibroblast Growth Factor 23 Gene Mediates Response to Phosphate, 1,25(OH)2D3, and LPS In Vivo.

Authors:  Seong Min Lee; Alex H Carlson; Melda Onal; Nancy A Benkusky; Mark B Meyer; J Wesley Pike
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

5.  Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.

Authors:  Zien Zhou; Meg J Jardine; Qiang Li; Brendon L Neuen; Christopher P Cannon; Dick de Zeeuw; Robert Edwards; Adeera Levin; Kenneth W Mahaffey; Vlado Perkovic; Bruce Neal; Richard I Lindley
Journal:  Stroke       Date:  2021-04-20       Impact factor: 7.914

6.  Association Cystatin C and Risk of Stroke in Elderly Patients With Obstructive Sleep Apnea: A Prospective Cohort Study.

Authors:  Xiaofeng Su; Yinghui Gao; Weihao Xu; JianHua Li; Kaibing Chen; Yan Gao; JingJing Guo; LiBo Zhao; Huanhuan Wang; Xiaoshun Qian; Junling Lin; Jiming Han; Lin Liu
Journal:  Front Neurosci       Date:  2021-12-15       Impact factor: 4.677

Review 7.  Thrombolytic Enzymes of Microbial Origin: A Review.

Authors:  Deepti Diwan; Zeba Usmani; Minaxi Sharma; James W Nelson; Vijay Kumar Thakur; Graham Christie; Gustavo Molina; Vijai Kumar Gupta
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 6.208

8.  Effects of estimated glomerular filtration rate on clinical outcomes in patients with intracerebral hemorrhage.

Authors:  Zhaoxia Li; Zixiao Li; Qi Zhou; Hongqiu Gu; Yongjun Wang; Xingquan Zhao
Journal:  BMC Neurol       Date:  2022-01-10       Impact factor: 2.474

Review 9.  Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy.

Authors:  Farwa Altaf; Shourong Wu; Vivi Kasim
Journal:  Front Mol Biosci       Date:  2021-05-28

Review 10.  The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease.

Authors:  Naren Bao; Fangjie Chen; Di Dai
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.